메뉴 건너뛰기




Volumn 38, Issue 3, 2015, Pages 372-380

Cancer metabolomics in basic science perspective

Author keywords

Cancer metabolism; Metabolic enzymes; Metabolomics

Indexed keywords

2 HYDROXYGLUTARIC ACID; GLUTAMINE; ENZYME; PROTEIN;

EID: 84925517362     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-015-0552-4     Document Type: Review
Times cited : (26)

References (100)
  • 1
    • 80054767730 scopus 로고    scopus 로고
    • Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: Roles for fumarate in KEAP1 succination and Nrf2 signaling
    • 1:CAS:528:DC%2BC3MXhtlKrtrfM 22014577
    • Adam, J., et al. 2011. Renal cyst formation in Fh1-deficient mice is independent of the Hif/Phd pathway: Roles for fumarate in KEAP1 succination and Nrf2 signaling. Cancer Cell 20(4): 524-537.
    • (2011) Cancer Cell , vol.20 , Issue.4 , pp. 524-537
    • Adam, J.1
  • 2
    • 7944226627 scopus 로고    scopus 로고
    • Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
    • 1:CAS:528:DC%2BD2cXptlykt78%3D 15533718
    • Altenberg, B., and K.O. Greulich. 2004. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84(6): 1014-1020.
    • (2004) Genomics , vol.84 , Issue.6 , pp. 1014-1020
    • Altenberg, B.1    Greulich, K.O.2
  • 3
    • 84889591862 scopus 로고    scopus 로고
    • Metabolomics in cancer biomarker discovery: Current trends and future perspectives
    • 1:CAS:528:DC%2BC3sXhsFGnsLrK 24091079
    • Armitage, E.G., and C. Barbas. 2014. Metabolomics in cancer biomarker discovery: Current trends and future perspectives. Journal of Pharmaceutical and Biomedical Analysis 87: 1-11.
    • (2014) Journal of Pharmaceutical and Biomedical Analysis , vol.87 , pp. 1-11
    • Armitage, E.G.1    Barbas, C.2
  • 4
    • 68949092126 scopus 로고    scopus 로고
    • Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2
    • 1:CAS:528:DC%2BD1MXhtV2qurzO 19033423
    • Baumann, F., et al. 2009. Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2. Neuro Oncology 11(4): 368-380.
    • (2009) Neuro Oncology , vol.11 , Issue.4 , pp. 368-380
    • Baumann, F.1
  • 5
    • 33745519159 scopus 로고    scopus 로고
    • Lactate stimulates endothelial cell migration
    • Beckert, S., et al. 2006. Lactate stimulates endothelial cell migration. Wound Repair and Regeneration 14(3): 321-324.
    • (2006) Wound Repair and Regeneration , vol.14 , Issue.3 , pp. 321-324
    • Beckert, S.1
  • 6
    • 84892860969 scopus 로고    scopus 로고
    • A review of applications of metabolomics in cancer
    • 1:CAS:528:DC%2BC3sXht1ejur7E 24958139
    • Beger, R.D. 2013. A review of applications of metabolomics in cancer. Metabolites 3(3): 552-574.
    • (2013) Metabolites , vol.3 , Issue.3 , pp. 552-574
    • Beger, R.D.1
  • 7
    • 79953700548 scopus 로고    scopus 로고
    • Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia
    • 1:CAS:528:DC%2BC3MXkslagurc%3D 21454467
    • Boissel, N., et al. 2011. Differential prognosis impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia. Blood 117(13): 3696-3697.
    • (2011) Blood , vol.117 , Issue.13 , pp. 3696-3697
    • Boissel, N.1
  • 8
    • 84864106022 scopus 로고    scopus 로고
    • Determining in vivo phosphorylation sites using mass spectrometry
    • Chapter 18: p. Unit18 19 1-27
    • Breitkopf, S.B., and J.M. Asara 2012. Determining in vivo phosphorylation sites using mass spectrometry. Current Protocols in Molecular Biology. Chapter 18: p. Unit18 19 1-27.
    • (2012) Current Protocols in Molecular Biology
    • Breitkopf, S.B.1    Asara, J.M.2
  • 9
    • 77957122174 scopus 로고    scopus 로고
    • The engine driving the ship: Metabolic steering of cell proliferation and death
    • 1:CAS:528:DC%2BC3cXhtFylur3L 20861880
    • Buchakjian, M.R., and S. Kornbluth. 2010. The engine driving the ship: Metabolic steering of cell proliferation and death. Nature Reviews Molecular Cell Biology 11(10): 715-727.
    • (2010) Nature Reviews Molecular Cell Biology , vol.11 , Issue.10 , pp. 715-727
    • Buchakjian, M.R.1    Kornbluth, S.2
  • 10
    • 84868019043 scopus 로고    scopus 로고
    • Cancer cell metabolism: One hallmark, many faces
    • 1:CAS:528:DC%2BC38XhsFagtLrJ 23009760
    • Cantor, J.R., and D.M. Sabatini. 2012. Cancer cell metabolism: One hallmark, many faces. Cancer Discovery 2(10): 881-898.
    • (2012) Cancer Discovery , vol.2 , Issue.10 , pp. 881-898
    • Cantor, J.R.1    Sabatini, D.M.2
  • 11
    • 84869082905 scopus 로고    scopus 로고
    • Serine is a natural ligand and allosteric activator of pyruvate kinase M2
    • 1:CAS:528:DC%2BC38XhsV2rsL7K 23064226
    • Chaneton, B., et al. 2012. Serine is a natural ligand and allosteric activator of pyruvate kinase M2. Nature 491(7424): 458-462.
    • (2012) Nature , vol.491 , Issue.7424 , pp. 458-462
    • Chaneton, B.1
  • 12
    • 79957774646 scopus 로고    scopus 로고
    • Pyruvate carboxylase is required for glutamine-independent growth of tumor cells
    • 1:CAS:528:DC%2BC3MXntVGqur4%3D
    • Cheng, T., et al. 2011. Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proceedings of the National Academy of Sciences USA 108(21): 8674-8679.
    • (2011) Proceedings of the National Academy of Sciences USA , vol.108 , Issue.21 , pp. 8674-8679
    • Cheng, T.1
  • 13
    • 79751530369 scopus 로고    scopus 로고
    • The prognostic impact and stability of isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
    • 1:CAS:528:DC%2BC3MXhs1amsrY%3D 21079611
    • Chou, W.C., et al. 2011. The prognostic impact and stability of isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia. Leukemia 25(2): 246-253.
    • (2011) Leukemia , vol.25 , Issue.2 , pp. 246-253
    • Chou, W.C.1
  • 14
    • 79955547561 scopus 로고    scopus 로고
    • The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
    • 1:CAS:528:DC%2BC3MXktFahs74%3D 21460794
    • Chowdhury, R., et al. 2011. The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases. EMBO Reports 12(5): 463-469.
    • (2011) EMBO Reports , vol.12 , Issue.5 , pp. 463-469
    • Chowdhury, R.1
  • 15
    • 84866488967 scopus 로고    scopus 로고
    • Metabolomics in cancer: A bench-to-bedside intersection
    • Claudino, W.M., et al. 2012. Metabolomics in cancer: A bench-to-bedside intersection. Critical Reviews in Oncology Hematology 84(1): 1-7.
    • (2012) Critical Reviews in Oncology Hematology , vol.84 , Issue.1 , pp. 1-7
    • Claudino, W.M.1
  • 16
    • 84860512005 scopus 로고    scopus 로고
    • Links between metabolism and cancer
    • 1:CAS:528:DC%2BC38XmslOgtrk%3D
    • Dang, C.V. 2012. Links between metabolism and cancer. Genes & Development 26(9): 877-890.
    • (2012) Genes & Development , vol.26 , Issue.9 , pp. 877-890
    • Dang, C.V.1
  • 17
    • 72049125350 scopus 로고    scopus 로고
    • Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
    • 1:CAS:528:DC%2BD1MXhsVGlurzE 19935646
    • Dang, L., et al. 2009. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462(7274): 739-744.
    • (2009) Nature , vol.462 , Issue.7274 , pp. 739-744
    • Dang, L.1
  • 18
    • 84903698645 scopus 로고    scopus 로고
    • Targeted cancer therapeutics: Biosynthetic and energetic pathways characterized by metabolomics and the interplay with key cancer regulatory factors
    • 1:CAS:528:DC%2BC2cXpt1Wht7w%3D 23859615
    • Dang, N.H., et al. 2014. Targeted cancer therapeutics: Biosynthetic and energetic pathways characterized by metabolomics and the interplay with key cancer regulatory factors. Current Pharmaceutical Design 20(15): 2637-2647.
    • (2014) Current Pharmaceutical Design , vol.20 , Issue.15 , pp. 2637-2647
    • Dang, N.H.1
  • 19
    • 75149148563 scopus 로고    scopus 로고
    • Q's next: The diverse functions of glutamine in metabolism, cell biology and cancer
    • 1:CAS:528:DC%2BD1MXhtlers7fE 19881548
    • DeBerardinis, R.J., and T. Cheng. 2010. Q's next: The diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29(3): 313-324.
    • (2010) Oncogene , vol.29 , Issue.3 , pp. 313-324
    • Deberardinis, R.J.1    Cheng, T.2
  • 20
    • 37449034854 scopus 로고    scopus 로고
    • Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis
    • 1:CAS:528:DC%2BD1cXisVOjtQ%3D%3D
    • DeBerardinis, R.J., et al. 2007. Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proceedings of the National Academy of Sciences USA 104(49): 19345-19350.
    • (2007) Proceedings of the National Academy of Sciences USA , vol.104 , Issue.49 , pp. 19345-19350
    • Deberardinis, R.J.1
  • 21
    • 0028902940 scopus 로고
    • Isotopomer analysis of citric acid cycle and gluconeogenesis in rat liver. Reversibility of isocitrate dehydrogenase and involvement of ATP-citrate lyase in gluconeogenesis
    • 1:CAS:528:DyaK2MXltlWnsrc%3D 7730304
    • Des Rosiers, C., et al. 1995. Isotopomer analysis of citric acid cycle and gluconeogenesis in rat liver. Reversibility of isocitrate dehydrogenase and involvement of ATP-citrate lyase in gluconeogenesis. Journal of Biological Chemistry 270(17): 10027-10036.
    • (1995) Journal of Biological Chemistry , vol.270 , Issue.17 , pp. 10027-10036
    • Des Rosiers, C.1
  • 22
    • 84855732698 scopus 로고    scopus 로고
    • Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids
    • 1:CAS:528:DC%2BC38XivVantL8%3D 22364616
    • Duarte, I.F., and A.M. Gil. 2012. Metabolic signatures of cancer unveiled by NMR spectroscopy of human biofluids. Progress in Nuclear Magnetic Resonance Spectroscopy 62: 51-74.
    • (2012) Progress in Nuclear Magnetic Resonance Spectroscopy , vol.62 , pp. 51-74
    • Duarte, I.F.1    Gil, A.M.2
  • 23
    • 18844406001 scopus 로고    scopus 로고
    • Measuring the metabolome: Current analytical technologies
    • 1:CAS:528:DC%2BD2MXjsFOnurw%3D 15852128
    • Dunn, W.B., N.J. Bailey, and H.E. Johnson. 2005. Measuring the metabolome: Current analytical technologies. Analyst 130(5): 606-625.
    • (2005) Analyst , vol.130 , Issue.5 , pp. 606-625
    • Dunn, W.B.1    Bailey, N.J.2    Johnson, H.E.3
  • 24
    • 84890209181 scopus 로고    scopus 로고
    • Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia
    • 1:CAS:528:DC%2BC3sXhvFCjs7fF 24301801
    • Fan, J., et al. 2013. Glutamine-driven oxidative phosphorylation is a major ATP source in transformed mammalian cells in both normoxia and hypoxia. Molecular systems biology 9: 712.
    • (2013) Molecular Systems Biology , vol.9 , pp. 712
    • Fan, J.1
  • 25
    • 84902332213 scopus 로고    scopus 로고
    • Quantitative flux analysis reveals folate-dependent NADPH production
    • 1:CAS:528:DC%2BC2cXps1WmtLc%3D 24805240
    • Fan, J., et al. 2014. Quantitative flux analysis reveals folate-dependent NADPH production. Nature 510(7504): 298-302.
    • (2014) Nature , vol.510 , Issue.7504 , pp. 298-302
    • Fan, J.1
  • 26
    • 34247352844 scopus 로고    scopus 로고
    • Inhibitory effect of tumor cell-derived lactic acid on human T cells
    • 1:CAS:528:DC%2BD2sXkvFCitLs%3D 17255361
    • Fischer, K., et al. 2007. Inhibitory effect of tumor cell-derived lactic acid on human T cells. Blood 109(9): 3812-3819.
    • (2007) Blood , vol.109 , Issue.9 , pp. 3812-3819
    • Fischer, K.1
  • 27
    • 0037731447 scopus 로고    scopus 로고
    • Lactate-sensitive response elements in genes involved in hyaluronan catabolism
    • 1:CAS:528:DC%2BD3sXjsVGmsLw%3D 12732217
    • Formby, B., and R. Stern. 2003. Lactate-sensitive response elements in genes involved in hyaluronan catabolism. Biochemical and Biophysical Research Communications 305(1): 203-208.
    • (2003) Biochemical and Biophysical Research Communications , vol.305 , Issue.1 , pp. 203-208
    • Formby, B.1    Stern, R.2
  • 28
    • 64749116346 scopus 로고    scopus 로고
    • C-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism
    • 1:CAS:528:DC%2BD1MXhvFKjtrY%3D 19219026
    • Gao, P., et al. 2009. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458(7239): 762-765.
    • (2009) Nature , vol.458 , Issue.7239 , pp. 762-765
    • Gao, P.1
  • 29
    • 79960029992 scopus 로고    scopus 로고
    • Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release
    • 1:CAS:528:DC%2BC3MXpvVegsbg%3D 21617859
    • Goetze, K., et al. 2011. Lactate enhances motility of tumor cells and inhibits monocyte migration and cytokine release. International Journal of Oncology 39(2): 453-463.
    • (2011) International Journal of Oncology , vol.39 , Issue.2 , pp. 453-463
    • Goetze, K.1
  • 30
    • 33344467760 scopus 로고    scopus 로고
    • Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
    • 1:CAS:528:DC%2BD28XitFCht7s%3D 16278308
    • Gottfried, E., et al. 2006. Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. Blood 107(5): 2013-2021.
    • (2006) Blood , vol.107 , Issue.5 , pp. 2013-2021
    • Gottfried, E.1
  • 31
    • 28544446058 scopus 로고    scopus 로고
    • Mitochondrial tumour suppressors: A genetic and biochemical update
    • 1:CAS:528:DC%2BD2MXht1WitLfE 16327764
    • Gottlieb, E., and I.P. Tomlinson. 2005. Mitochondrial tumour suppressors: A genetic and biochemical update. Nature Reviews Cancer 5(11): 857-866.
    • (2005) Nature Reviews Cancer , vol.5 , Issue.11 , pp. 857-866
    • Gottlieb, E.1    Tomlinson, I.P.2
  • 32
    • 84903489573 scopus 로고    scopus 로고
    • IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism
    • 1:CAS:528:DC%2BC2cXps1Cmurw%3D 24755473
    • Grassian, A.R., et al. 2014. IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism. Cancer Research 74(12): 3317-3331.
    • (2014) Cancer Research , vol.74 , Issue.12 , pp. 3317-3331
    • Grassian, A.R.1
  • 33
    • 63549121490 scopus 로고    scopus 로고
    • NRF2 and KEAP1 mutations: Permanent activation of an adaptive response in cancer
    • 1:CAS:528:DC%2BD1MXksVSkt7k%3D 19321346
    • Hayes, J.D., and M. McMahon. 2009. NRF2 and KEAP1 mutations: Permanent activation of an adaptive response in cancer. Trends in Biochemical Sciences 34(4): 176-188.
    • (2009) Trends in Biochemical Sciences , vol.34 , Issue.4 , pp. 176-188
    • Hayes, J.D.1    McMahon, M.2
  • 34
    • 84883497454 scopus 로고    scopus 로고
    • Glutamine and cancer: Cell biology, physiology, and clinical opportunities
    • 1:CAS:528:DC%2BC3sXhsVenu7bL 23999442
    • Hensley, C.T., A.T. Wasti, and R.J. DeBerardinis. 2013. Glutamine and cancer: Cell biology, physiology, and clinical opportunities. The Journal of Clinical Investigation 123(9): 3678-3684.
    • (2013) The Journal of Clinical Investigation , vol.123 , Issue.9 , pp. 3678-3684
    • Hensley, C.T.1    Wasti, A.T.2    Deberardinis, R.J.3
  • 35
    • 81155126061 scopus 로고    scopus 로고
    • Lactate: A metabolic key player in cancer
    • 1:CAS:528:DC%2BC3MXhsVKhu7jK 22084445
    • Hirschhaeuser, F., U.G. Sattler, and W. Mueller-Klieser. 2011. Lactate: A metabolic key player in cancer. Cancer Research 71(22): 6921-6925.
    • (2011) Cancer Research , vol.71 , Issue.22 , pp. 6921-6925
    • Hirschhaeuser, F.1    Sattler, U.G.2    Mueller-Klieser, W.3
  • 36
    • 0029591465 scopus 로고
    • Glutamine metabolism in AS-30D hepatoma cells. Evidence for its conversion into lipids via reductive carboxylation
    • 1:CAS:528:DyaK28Xislektg%3D%3D 8751155
    • Holleran, A.L., et al. 1995. Glutamine metabolism in AS-30D hepatoma cells. Evidence for its conversion into lipids via reductive carboxylation. Molecular and Cellular Biochemistry 152(2): 95-101.
    • (1995) Molecular and Cellular Biochemistry , vol.152 , Issue.2 , pp. 95-101
    • Holleran, A.L.1
  • 37
    • 52649107626 scopus 로고    scopus 로고
    • Cancer cell metabolism: Warburg and beyond
    • 1:CAS:528:DC%2BD1cXhtFCqs7jK 18775299
    • Hsu, P.P., and D.M. Sabatini. 2008. Cancer cell metabolism: Warburg and beyond. Cell 134(5): 703-707.
    • (2008) Cell , vol.134 , Issue.5 , pp. 703-707
    • Hsu, P.P.1    Sabatini, D.M.2
  • 38
    • 77952212178 scopus 로고    scopus 로고
    • Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
    • 1:CAS:528:DC%2BC3cXlsFWhsbo%3D
    • Hu, W., et al. 2010. Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proceedings of the National Academy of Sciences USA 107(16): 7455-7460.
    • (2010) Proceedings of the National Academy of Sciences USA , vol.107 , Issue.16 , pp. 7455-7460
    • Hu, W.1
  • 39
    • 79955492012 scopus 로고    scopus 로고
    • Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells
    • 1:CAS:528:DC%2BC3MXltlGjtro%3D 21482715
    • Inami, Y., et al. 2011. Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. Journal of Cell Biology 193(2): 275-284.
    • (2011) Journal of Cell Biology , vol.193 , Issue.2 , pp. 275-284
    • Inami, Y.1
  • 40
    • 84861420588 scopus 로고    scopus 로고
    • Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation
    • 1:CAS:528:DC%2BC38Xnt1KgtL8%3D 22628656
    • Jain, M., et al. 2012. Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation. Science 336(6084): 1040-1044.
    • (2012) Science , vol.336 , Issue.6084 , pp. 1040-1044
    • Jain, M.1
  • 41
    • 84885944468 scopus 로고    scopus 로고
    • The emerging role of the Nrf2-Keap1 signaling pathway in cancer
    • 1:CAS:528:DC%2BC3sXhslCjt7zN
    • Jaramillo, M.C., and D.D. Zhang. 2013. The emerging role of the Nrf2-Keap1 signaling pathway in cancer. Genes & Development 27(20): 2179-2191.
    • (2013) Genes & Development , vol.27 , Issue.20 , pp. 2179-2191
    • Jaramillo, M.C.1    Zhang, D.D.2
  • 42
    • 78651318867 scopus 로고    scopus 로고
    • Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression
    • 1:CAS:528:DC%2BC3MXjsFSqsQ%3D%3D 21168877
    • Jentzmik, F., et al. 2011. Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression. Journal of Urology 185(2): 706-711.
    • (2011) Journal of Urology , vol.185 , Issue.2 , pp. 706-711
    • Jentzmik, F.1
  • 43
    • 84884192379 scopus 로고    scopus 로고
    • Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer
    • 1:CAS:528:DC%2BC3sXhsV2ru77N 24069390
    • Kennedy, K.M., et al. 2013. Catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer. PLoS One 8(9): e75154.
    • (2013) PLoS One , vol.8 , Issue.9 , pp. 75154
    • Kennedy, K.M.1
  • 44
    • 84862776918 scopus 로고    scopus 로고
    • Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
    • Koivunen, P., et al. 2012. Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation. Nature 483(7390): 485-488.
    • (2012) Nature , vol.483 , Issue.7390 , pp. 485-488
    • Koivunen, P.1
  • 45
    • 80052338863 scopus 로고    scopus 로고
    • Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia
    • 1:CAS:528:DC%2BC3MXhtFCktb3M 21852960
    • Kung, H.N., J.R. Marks, and J.T. Chi. 2011. Glutamine synthetase is a genetic determinant of cell type-specific glutamine independence in breast epithelia. PLoS Genetics 7(8): e1002229.
    • (2011) PLoS Genetics , vol.7 , Issue.8 , pp. 1002229
    • Kung, H.N.1    Marks, J.R.2    Chi, J.T.3
  • 46
    • 84920448829 scopus 로고    scopus 로고
    • NMR spectroscopy for metabolomics and metabolic profiling
    • Larive, C.K., G.A. Barding, and M.M. Dinges. 2014. NMR spectroscopy for metabolomics and metabolic profiling. Analytical chemistry 87(1): 133-146.
    • (2014) Analytical Chemistry , vol.87 , Issue.1 , pp. 133-146
    • Larive, C.K.1    Barding, G.A.2    Dinges, M.M.3
  • 47
    • 79960384696 scopus 로고    scopus 로고
    • Mass spectrometry strategies in metabolomics
    • 1:CAS:528:DC%2BC3MXovFCksbY%3D 21632543
    • Lei, Z., D.V. Huhman, and L.W. Sumner. 2011. Mass spectrometry strategies in metabolomics. Journal of Biological Chemistry 286(29): 25435-25442.
    • (2011) Journal of Biological Chemistry , vol.286 , Issue.29 , pp. 25435-25442
    • Lei, Z.1    Huhman, D.V.2    Sumner, L.W.3
  • 48
    • 84890021455 scopus 로고    scopus 로고
    • Review of mass spectrometry-based metabolomics in cancer research
    • 1:CAS:528:DC%2BC3sXhvV2rsLfL
    • Liesenfeld, D.B., et al. 2013. Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiology Biomarkers & Prevention 22(12): 2182-2201.
    • (2013) Cancer Epidemiology Biomarkers & Prevention , vol.22 , Issue.12 , pp. 2182-2201
    • Liesenfeld, D.B.1
  • 49
    • 84881177291 scopus 로고    scopus 로고
    • Serine, glycine and one-carbon units: Cancer metabolism in full circle
    • 1:CAS:528:DC%2BC3sXhtVGrsLzE 23822983
    • Locasale, J.W. 2013. Serine, glycine and one-carbon units: Cancer metabolism in full circle. Nature Reviews Cancer 13(8): 572-583.
    • (2013) Nature Reviews Cancer , vol.13 , Issue.8 , pp. 572-583
    • Locasale, J.W.1
  • 50
    • 0037189542 scopus 로고    scopus 로고
    • Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis
    • 1:CAS:528:DC%2BD38XltF2nsr4%3D 11943784
    • Lu, H., R.A. Forbes, and A. Verma. 2002. Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. Journal of Biological Chemistry 277(26): 23111-23115.
    • (2002) Journal of Biological Chemistry , vol.277 , Issue.26 , pp. 23111-23115
    • Lu, H.1    Forbes, R.A.2    Verma, A.3
  • 51
    • 84868117861 scopus 로고    scopus 로고
    • Metabolism of [U-13 C]glucose in human brain tumors in vivo
    • 1:CAS:528:DC%2BC38XhsFGqtLrO 22419606
    • Maher, E.A., et al. 2012. Metabolism of [U-13 C]glucose in human brain tumors in vivo. NMR in Biomedicine 25(11): 1234-1244.
    • (2012) NMR in Biomedicine , vol.25 , Issue.11 , pp. 1234-1244
    • Maher, E.A.1
  • 52
    • 84856014884 scopus 로고    scopus 로고
    • Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia
    • 1:CAS:528:DC%2BC3MXhsV2gt7fP
    • Metallo, C.M., et al. 2012. Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481(7381): 380-384.
    • (2012) Nature , vol.481 , Issue.7381 , pp. 380-384
    • Metallo, C.M.1
  • 53
    • 84878659022 scopus 로고    scopus 로고
    • Sum of the parts: Mass spectrometry-based metabolomics
    • 1:CAS:528:DC%2BC3sXjtVCms7s%3D 23442130
    • Milne, S.B., et al. 2013. Sum of the parts: Mass spectrometry-based metabolomics. Biochemistry 52(22): 3829-3840.
    • (2013) Biochemistry , vol.52 , Issue.22 , pp. 3829-3840
    • Milne, S.B.1
  • 54
    • 33847367741 scopus 로고    scopus 로고
    • Energy metabolism in tumor cells
    • 1:CAS:528:DC%2BD2sXjslait7g%3D 17302740
    • Moreno-Sanchez, R., et al. 2007. Energy metabolism in tumor cells. FEBS Journal 274(6): 1393-1418.
    • (2007) FEBS Journal , vol.274 , Issue.6 , pp. 1393-1418
    • Moreno-Sanchez, R.1
  • 55
    • 84855987831 scopus 로고    scopus 로고
    • Reductive carboxylation supports growth in tumour cells with defective mitochondria
    • 1:CAS:528:DC%2BC3MXhsV2gt73F
    • Mullen, A.R., et al. 2012. Reductive carboxylation supports growth in tumour cells with defective mitochondria. Nature 481(7381): 385-388.
    • (2012) Nature , vol.481 , Issue.7381 , pp. 385-388
    • Mullen, A.R.1
  • 56
    • 84902343371 scopus 로고    scopus 로고
    • Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects
    • 1:CAS:528:DC%2BC2cXosl2htb0%3D 24857658
    • Mullen, A.R., et al. 2014. Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects. Cell Reports 7(5): 1679-1690.
    • (2014) Cell Reports , vol.7 , Issue.5 , pp. 1679-1690
    • Mullen, A.R.1
  • 57
    • 54549091125 scopus 로고    scopus 로고
    • Systems biology: Metabonomics
    • 1:CAS:528:DC%2BD1cXht1yju7zN 18948945
    • Nicholson, J.K., and J.C. Lindon. 2008. Systems biology: Metabonomics. Nature 455(7216): 1054-1056.
    • (2008) Nature , vol.455 , Issue.7216 , pp. 1054-1056
    • Nicholson, J.K.1    Lindon, J.C.2
  • 59
    • 84858055067 scopus 로고    scopus 로고
    • Recent advances in metabolomics in oncology
    • O'Connell, T.M. 2012. Recent advances in metabolomics in oncology. Bioanalysis 4(4): 431-451.
    • (2012) Bioanalysis , vol.4 , Issue.4 , pp. 431-451
    • O'Connell, T.M.1
  • 60
    • 80054772589 scopus 로고    scopus 로고
    • An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma
    • 1:CAS:528:DC%2BC3MXhtlKrtrbF 22014576
    • Ooi, A., et al. 2011. An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell 20(4): 511-523.
    • (2011) Cancer Cell , vol.20 , Issue.4 , pp. 511-523
    • Ooi, A.1
  • 61
    • 33846109344 scopus 로고    scopus 로고
    • Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics
    • 1:CAS:528:DC%2BD2sXlsFOisA%3D%3D 16955259
    • Pan, Z., and D. Raftery. 2007. Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Analytical and Bioanalytical Chemistry 387(2): 525-527.
    • (2007) Analytical and Bioanalytical Chemistry , vol.387 , Issue.2 , pp. 525-527
    • Pan, Z.1    Raftery, D.2
  • 62
    • 52949127312 scopus 로고    scopus 로고
    • An integrated genomic analysis of human glioblastoma multiforme
    • 1:CAS:528:DC%2BD1cXhtFCrtLrE 18772396
    • Parsons, D.W., et al. 2008. An integrated genomic analysis of human glioblastoma multiforme. Science 321(5897): 1807-1812.
    • (2008) Science , vol.321 , Issue.5897 , pp. 1807-1812
    • Parsons, D.W.1
  • 63
    • 84858790233 scopus 로고    scopus 로고
    • Metabolomics: The apogee of the omics trilogy
    • 1:CAS:528:DC%2BC38XksVent78%3D 22436749
    • Patti, G.J., O. Yanes, and G. Siuzdak. 2012. Metabolomics: The apogee of the omics trilogy. Nature Reviews Molecular Cell Biology 13(4): 263-269.
    • (2012) Nature Reviews Molecular Cell Biology , vol.13 , Issue.4 , pp. 263-269
    • Patti, G.J.1    Yanes, O.2    Siuzdak, G.3
  • 64
    • 26444570010 scopus 로고    scopus 로고
    • Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations
    • 1:CAS:528:DC%2BD2MXmt1ert78%3D 15987702
    • Pollard, P.J., et al. 2005. Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Human Molecular Genetics 14(15): 2231-2239.
    • (2005) Human Molecular Genetics , vol.14 , Issue.15 , pp. 2231-2239
    • Pollard, P.J.1
  • 65
    • 80051923932 scopus 로고    scopus 로고
    • Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
    • 1:CAS:528:DC%2BC3MXhtVOku7rL 21760589
    • Possemato, R., et al. 2011. Functional genomics reveal that the serine synthesis pathway is essential in breast cancer. Nature 476(7360): 346-350.
    • (2011) Nature , vol.476 , Issue.7360 , pp. 346-350
    • Possemato, R.1
  • 66
    • 84865520089 scopus 로고    scopus 로고
    • IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics
    • 1:CAS:528:DC%2BC38XhtFWmt7bL 22763442
    • Sasaki, M., et al. 2012. IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature 488(7413): 656-659.
    • (2012) Nature , vol.488 , Issue.7413 , pp. 656-659
    • Sasaki, M.1
  • 67
    • 77957771067 scopus 로고    scopus 로고
    • IDH1 mutations are detected in 6.6 % of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status
    • 1:CAS:528:DC%2BC3MXhtFGktbc%3D 20805365
    • Schnittger, S., et al. 2010. IDH1 mutations are detected in 6.6 % of 1414 AML patients and are associated with intermediate risk karyotype and unfavorable prognosis in adults younger than 60 years and unmutated NPM1 status. Blood 116(25): 5486-5496.
    • (2010) Blood , vol.116 , Issue.25 , pp. 5486-5496
    • Schnittger, S.1
  • 68
    • 84869009687 scopus 로고    scopus 로고
    • How cancer metabolism is tuned for proliferation and vulnerable to disruption
    • 1:CAS:528:DC%2BC38Xhs1Ogt77F 23151579
    • Schulze, A., and A.L. Harris. 2012. How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature 491(7424): 364-373.
    • (2012) Nature , vol.491 , Issue.7424 , pp. 364-373
    • Schulze, A.1    Harris, A.L.2
  • 69
    • 84902182150 scopus 로고    scopus 로고
    • Mechanism and function of oxidative reversal of DNA and RNA methylation
    • 1:CAS:528:DC%2BC2cXhtFOhtrnP 24905787
    • Shen, L., et al. 2014. Mechanism and function of oxidative reversal of DNA and RNA methylation. Annual Review of Biochemistry 83: 585-614.
    • (2014) Annual Review of Biochemistry , vol.83 , pp. 585-614
    • Shen, L.1
  • 70
    • 84908402760 scopus 로고    scopus 로고
    • L-2-Hydroxyglutarate: An epigenetic modifier and putative oncometabolite in renal cancer
    • 1:CAS:528:DC%2BC2cXhvVyju7nF 25182153
    • Shim, E.H., et al. 2014. L-2-Hydroxyglutarate: An epigenetic modifier and putative oncometabolite in renal cancer. Cancer Discovery 4(11): 1290-1298.
    • (2014) Cancer Discovery , vol.4 , Issue.11 , pp. 1290-1298
    • Shim, E.H.1
  • 71
    • 75149138761 scopus 로고    scopus 로고
    • Prolyl hydroxylases and therapeutics
    • 1:CAS:528:DC%2BC3cXitVahsbw%3D
    • Smith, T.G., and N.P. Talbot. 2010. Prolyl hydroxylases and therapeutics. Antioxidants & Redox Signaling 12(4): 431-433.
    • (2010) Antioxidants & Redox Signaling , vol.12 , Issue.4 , pp. 431-433
    • Smith, T.G.1    Talbot, N.P.2
  • 72
    • 57449097020 scopus 로고    scopus 로고
    • Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
    • 2582933 1:CAS:528:DC%2BD1cXhsVKgu7rI 19033663
    • Sonveaux, P., et al. 2008. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. The Journal of Clinical Investigation 118(12): 3930-3942.
    • (2008) The Journal of Clinical Investigation , vol.118 , Issue.12 , pp. 3930-3942
    • Sonveaux, P.1
  • 73
    • 59449097019 scopus 로고    scopus 로고
    • Clinical applications of metabolomics in oncology: A review
    • 1:CAS:528:DC%2BD1MXlvFeksw%3D%3D 19147747
    • Spratlin, J.L., N.J. Serkova, and S.G. Eckhardt. 2009. Clinical applications of metabolomics in oncology: A review. Clinical Cancer Research 15(2): 431-440.
    • (2009) Clinical Cancer Research , vol.15 , Issue.2 , pp. 431-440
    • Spratlin, J.L.1    Serkova, N.J.2    Eckhardt, S.G.3
  • 74
    • 60149091657 scopus 로고    scopus 로고
    • Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression
    • 1:CAS:528:DC%2BD1MXhslCnt70%3D 19212411
    • Sreekumar, A., et al. 2009. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 457(7231): 910-914.
    • (2009) Nature , vol.457 , Issue.7231 , pp. 910-914
    • Sreekumar, A.1
  • 75
    • 0036347515 scopus 로고    scopus 로고
    • Lactate stimulates fibroblast expression of hyaluronan and CD44: The Warburg effect revisited
    • 1:CAS:528:DC%2BD38XjtFyisrk%3D 11978005
    • Stern, R., et al. 2002. Lactate stimulates fibroblast expression of hyaluronan and CD44: The Warburg effect revisited. Experimental Cell Research 276(1): 24-31.
    • (2002) Experimental Cell Research , vol.276 , Issue.1 , pp. 24-31
    • Stern, R.1
  • 76
    • 77952227625 scopus 로고    scopus 로고
    • Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species
    • 1:CAS:528:DC%2BC3cXlsFWhsbs%3D
    • Suzuki, S., et al. 2010. Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proceedings of the National Academy of Sciences USA 107(16): 7461-7466.
    • (2010) Proceedings of the National Academy of Sciences USA , vol.107 , Issue.16 , pp. 7461-7466
    • Suzuki, S.1
  • 77
    • 12344297755 scopus 로고    scopus 로고
    • Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas
    • 1:CAS:528:DC%2BD2MXkvFKlsQ%3D%3D 15663956
    • Szeliga, M., et al. 2005. Lack of expression of the liver-type glutaminase (LGA) mRNA in human malignant gliomas. Neuroscience Letters 374(3): 171-173.
    • (2005) Neuroscience Letters , vol.374 , Issue.3 , pp. 171-173
    • Szeliga, M.1
  • 78
    • 84867130104 scopus 로고    scopus 로고
    • Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth
    • van den Heuvel, A.P., et al. 2012. Analysis of glutamine dependency in non-small cell lung cancer: GLS1 splice variant GAC is essential for cancer cell growth. Cancer Biology & Therapy 13(12): 1185-1194.
    • (2012) Cancer Biology & Therapy , vol.13 , Issue.12 , pp. 1185-1194
    • Van Den Heuvel, A.P.1
  • 79
    • 80052242132 scopus 로고    scopus 로고
    • Targeting cancer metabolism: A therapeutic window opens
    • 1:CAS:528:DC%2BC3MXhtFSltb3J 21878982
    • Vander Heiden, M.G. 2011. Targeting cancer metabolism: A therapeutic window opens. Nature reviews Drug discovery 10(9): 671-684.
    • (2011) Nature Reviews Drug Discovery , vol.10 , Issue.9 , pp. 671-684
    • Vander Heiden, M.G.1
  • 80
    • 66249108601 scopus 로고    scopus 로고
    • Understanding the Warburg effect: The metabolic requirements of cell proliferation
    • 1:CAS:528:DC%2BD1MXmtVKlsbg%3D 19460998
    • Vander Heiden, M.G., L.C. Cantley, and C.B. Thompson. 2009. Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324(5930): 1029-1033.
    • (2009) Science , vol.324 , Issue.5930 , pp. 1029-1033
    • Vander Heiden, M.G.1    Cantley, L.C.2    Thompson, C.B.3
  • 81
    • 79953329777 scopus 로고    scopus 로고
    • Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB/IL-8 pathway that drives tumor angiogenesis
    • 1:CAS:528:DC%2BC3MXktVOjtLg%3D 21300765
    • Vegran, F., et al. 2011. Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB/IL-8 pathway that drives tumor angiogenesis. Cancer Research 71(7): 2550-2560.
    • (2011) Cancer Research , vol.71 , Issue.7 , pp. 2550-2560
    • Vegran, F.1
  • 82
    • 12444279265 scopus 로고
    • On the origin of cancer cells
    • 1:STN:280:DyaG28%2FltV2ktQ%3D%3D 13298683
    • Warburg, O. 1956. On the origin of cancer cells. Science 123(3191): 309-314.
    • (1956) Science , vol.123 , Issue.3191 , pp. 309-314
    • Warburg, O.1
  • 84
    • 84858604270 scopus 로고    scopus 로고
    • Metabolic reprogramming: A cancer hallmark even warburg did not anticipate
    • 1:CAS:528:DC%2BC38Xkt1ylsbc%3D 22439925
    • Ward, P.S., and C.B. Thompson. 2012a. Metabolic reprogramming: A cancer hallmark even warburg did not anticipate. Cancer Cell 21(3): 297-308.
    • (2012) Cancer Cell , vol.21 , Issue.3 , pp. 297-308
    • Ward, P.S.1    Thompson, C.B.2
  • 86
    • 77649305610 scopus 로고    scopus 로고
    • The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate
    • 1:CAS:528:DC%2BC3cXlsVWqtLg%3D 20171147
    • Ward, P.S., et al. 2010. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17(3): 225-234.
    • (2010) Cancer Cell , vol.17 , Issue.3 , pp. 225-234
    • Ward, P.S.1
  • 87
    • 77954197821 scopus 로고    scopus 로고
    • High-throughput and multiplexed LC/MS/MRM method for targeted metabolomics
    • 1:CAS:528:DC%2BC3cXmvF2qsb4%3D 20524683
    • Wei, R., G. Li, and A.B. Seymour. 2010. High-throughput and multiplexed LC/MS/MRM method for targeted metabolomics. Analytical Chemistry 82(13): 5527-5533.
    • (2010) Analytical Chemistry , vol.82 , Issue.13 , pp. 5527-5533
    • Wei, R.1    Li, G.2    Seymour, A.B.3
  • 88
    • 77952737658 scopus 로고    scopus 로고
    • Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity
    • 1:CAS:528:DC%2BC3cXmsFWmurs%3D
    • Weinberg, F., et al. 2010. Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity. Proceedings of the National Academy of Sciences USA 107(19): 8788-8793.
    • (2010) Proceedings of the National Academy of Sciences USA , vol.107 , Issue.19 , pp. 8788-8793
    • Weinberg, F.1
  • 89
    • 84921340449 scopus 로고    scopus 로고
    • Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism
    • Wen, H., et al. 2014. Metabolomic comparison between cells over-expressing isocitrate dehydrogenase 1 and 2 mutants and the effects of an inhibitor on the metabolism. Journal of Neurochemistry 132(2): 183-193.
    • (2014) Journal of Neurochemistry , vol.132 , Issue.2 , pp. 183-193
    • Wen, H.1
  • 90
    • 57749088701 scopus 로고    scopus 로고
    • Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction
    • 1:CAS:528:DC%2BD1cXhsV2rtL%2FK
    • Wise, D.R., et al. 2008. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proceedings of the National Academy of Sciences USA 105(48): 18782-18787.
    • (2008) Proceedings of the National Academy of Sciences USA , vol.105 , Issue.48 , pp. 18782-18787
    • Wise, D.R.1
  • 91
    • 83755178091 scopus 로고    scopus 로고
    • Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability
    • 1:CAS:528:DC%2BC3MXhs1GjsbvP
    • Wise, D.R., et al. 2011. Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of alpha-ketoglutarate to citrate to support cell growth and viability. Proceedings of the National Academy of Sciences USA 108(49): 19611-19616.
    • (2011) Proceedings of the National Academy of Sciences USA , vol.108 , Issue.49 , pp. 19611-19616
    • Wise, D.R.1
  • 92
    • 33644828213 scopus 로고    scopus 로고
    • Metabolomics: The principles and potential applications to transplantation
    • 1:CAS:528:DC%2BD2MXhtlGns7zI 16302993
    • Wishart, D.S. 2005. Metabolomics: The principles and potential applications to transplantation. American Journal of Transplantation 5(12): 2814-2820.
    • (2005) American Journal of Transplantation , vol.5 , Issue.12 , pp. 2814-2820
    • Wishart, D.S.1
  • 93
    • 84876148784 scopus 로고    scopus 로고
    • HMDB 3.0-The human metabolome database in 2013
    • 1:CAS:528:DC%2BC38XhvV2ktrnP 23161693
    • Wishart, D.S., et al. 2013. HMDB 3.0-the human metabolome database in 2013. Nucleic acids research 41: D801-D807.
    • (2013) Nucleic Acids Research , vol.41 , pp. 801-D807
    • Wishart, D.S.1
  • 94
    • 78651463452 scopus 로고    scopus 로고
    • Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases
    • 1:CAS:528:DC%2BC3MXpvValsQ%3D%3D 21251613
    • Xu, W., et al. 2011. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 19(1): 17-30.
    • (2011) Cancer Cell , vol.19 , Issue.1 , pp. 17-30
    • Xu, W.1
  • 95
    • 60849115270 scopus 로고    scopus 로고
    • IDH1 and IDH2 mutations in gliomas
    • 1:CAS:528:DC%2BD1MXitFWru7o%3D 19228619
    • Yan, H., et al. 2009. IDH1 and IDH2 mutations in gliomas. New England Journal of Medicine 360(8): 765-773.
    • (2009) New England Journal of Medicine , vol.360 , Issue.8 , pp. 765-773
    • Yan, H.1
  • 96
    • 84867562009 scopus 로고    scopus 로고
    • IDH1 and IDH2 mutations in tumorigenesis: Mechanistic insights and clinical perspectives
    • 1:CAS:528:DC%2BC38XhsFahu73E 23071358
    • Yang, H., et al. 2012. IDH1 and IDH2 mutations in tumorigenesis: Mechanistic insights and clinical perspectives. Clinical Cancer Research 18(20): 5562-5571.
    • (2012) Clinical Cancer Research , vol.18 , Issue.20 , pp. 5562-5571
    • Yang, H.1
  • 97
    • 84883513587 scopus 로고    scopus 로고
    • Oncometabolites: Linking altered metabolism with cancer
    • 1:CAS:528:DC%2BC3sXhsVenu7bP 23999438
    • Yang, M., T. Soga, and P.J. Pollard. 2013. Oncometabolites: Linking altered metabolism with cancer. The Journal of Clinical Investigation 123(9): 3652-3658.
    • (2013) The Journal of Clinical Investigation , vol.123 , Issue.9 , pp. 3652-3658
    • Yang, M.1    Soga, T.2    Pollard, P.J.3
  • 98
    • 84856087055 scopus 로고    scopus 로고
    • Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis
    • 1:CAS:528:DC%2BC38XhtFKgsbw%3D 22225612
    • Zhang, W.C., et al. 2012. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. Cell 148(1-2): 259-272.
    • (2012) Cell , vol.148 , Issue.1-2 , pp. 259-272
    • Zhang, W.C.1
  • 99
    • 84881475400 scopus 로고    scopus 로고
    • NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis
    • 1:CAS:528:DC%2BC3sXhtVKrtrnE 23828598
    • Zhang, A.H., et al. 2013. NMR-based metabolomics coupled with pattern recognition methods in biomarker discovery and disease diagnosis. Magnetic Resonance in Chemistry 51(9): 549-556.
    • (2013) Magnetic Resonance in Chemistry , vol.51 , Issue.9 , pp. 549-556
    • Zhang, A.H.1
  • 100
    • 64849098267 scopus 로고    scopus 로고
    • Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha
    • 1:CAS:528:DC%2BD1MXktFals7g%3D 19359588
    • Zhao, S., et al. 2009. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324(5924): 261-265.
    • (2009) Science , vol.324 , Issue.5924 , pp. 261-265
    • Zhao, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.